In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or area is cancerous. However, in the U.S., between 75% and 80% of breast biopsies are benign.

In a proof-of-concept study, researchers from the Keck School of Medicine of USC and the California Institute of Technology ...

Fluorescence molecular tomography (FMT) and allied optical imaging techniques represent advanced non‐invasive modalities that facilitate three‐dimensional visualisation of fluorescent probes within ...

Cardiovascular diseases remain one of the leading causes of mortality and morbidity worldwide. They are responsible for almost 31 percent of all deaths. India is also struggling with rising number […] ...

Professor of Medical Imaging at the University of Arizona Lars Furenlid, the project’s lead researcher. Professor of Radiology at UMass Chan Medical School Michael King. In order to better study and ...

The researchers combined two imaging methods, rotational ultrasound tomography (RUST) and photoacoustic tomography (PAT), to ...

The first intravascular imaging technology specifically designed for the brain could have implications in stroke and other neurovascular diseases BOSTON--(BUSINESS WIRE)--Spryte Medical, an ...

Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for ...

X-ray tomography is a powerful tool that enables scientists and engineers to peer inside of objects in 3D, including computer ...

Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of AxioView™ imaging fiber assemblies, designed for optical coherence tomography (OCT), near-infrared spectroscopy ...

Lumexa Imaging (LMRI) rated Buy: resilient outpatient imaging demand, hospital JV moat, and scale-driven FCF growth.